Showing results (1631-1640 of 5,709) with videos related to

Sort By:
Pageof 571
BMC Nephrology|December 14, 2016
The clinical and economic burden of pneumonia in patients enrolled in Medicare receiving dialysis: a retrospective, observational cohort studyScott Sibbel, Reiko Sato, Abigail Hunt, et al.
BMC Nephrology|November 23, 2016
Impact of residual urine volume decline on the survival of chronic hemodialysis patients in KinshasaVieux Momeme Mokoli, Ernest Kiswaya Sumaili, François Bompeka Lepira, et al.
BMC Nephrology|November 25, 2016
High prevalence of non-steroidal anti-inflammatory drug use among acute kidney injury survivors in the southern community cohort studyLoren Lipworth, Khaled Abdel-Kader, Jennifer Morse, et al.
BMC Nephrology|January 16, 2017
Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: results from the Chinese cohort study of chronic kidney disease (C-STRIDE)Jun Yuan, Xin-Rong Zou, Si-Ping Han, et al.
BMC Nephrology|October 25, 2016
Prognosis of patients with severe hyponatraemia is related not only to hyponatraemia but also to comorbidities and to medical management: results of an observational retrospective studyThierry Krummel, Eric Prinz, Marie-Astrid Metten, et al.
BMC Nephrology|October 25, 2016
Correction of metabolic acidosis improves insulin resistance in chronic kidney diseaseAntonio Bellasi, Lucia Di Micco, Domenico Santoro, et al.
BMC Nephrology|October 15, 2016
Haemodiafiltration elicits less platelet activation compared to haemodialysisGergely Becs, Renáta Hudák, Zsolt Fejes, et al.
BMC Nephrology|November 5, 2016
Fatal outcomes among patients on maintenance haemodialysis in sub-Saharan Africa: a 10-year audit from the Douala General Hospital in CameroonMarie Patrice Halle, Gloria Ashuntantang, Francois Folefack Kaze, et al.
BMC Nephrology|November 11, 2016
Relation of peritubular capillary features to class of lupus nephritisSirirat Anutrakulchai, Tanin Titipungul, Thanyaluk Pattay, et al.
BMC Nephrology|November 17, 2016
Competing risk of death and end-stage renal disease in incident chronic kidney disease (stages 3 to 5): the EPIRAN community-based studyCarole Ayav, Jean-Baptiste Beuscart, Serge Briançon, et al.
Pageof 571